Expression of Multidrug Resistance 1, Lung Resistance Protein and Breast Cancer Resistance Protein Genes in Chronic Leukemias

ISERI, Ozlem D.; KARS, Meltem D.; MUTLU, Pelin; AVCU, Ferit; URAL, Ali U.; GUNDUZ, Ufuk
June 2011
International Journal of Hematology & Oncology / UHOD: Uluslarar;Jun2011, Vol. 21 Issue 2, p92
Academic Journal
One of the major problems in treatment of leukemias is multidrug resistance, which is already present at diagnosis or develops after chemotherapy. The gene expression levels of multidrug resistance resistance 1 (MDR1), breast cancer resistance protein (BCRP) and lung resistance-resistance protein (LRP) were evaluated in blood samples of 20 CLL and 24 CML patients using RT-PCR. MDR1, BCRP and LRP expression levels were detected in 65%, 20% and 45% of CLL patients, and in 54%, 37% and 25% of CML patients, respectively. 20% of CLL patients and 33% of CML patients expressed none of the genes. The other 20% of CLL patients expressed all the genes. 17% of CML patients expressed all of these genes, and two of them rapidly progressed to acute leukemia. MDR and LRP expressions seem to be frequent events in CLL and CML patients; however no conclusion can be drawn on their prognostic role and response to the treatment.


Related Articles

  • Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. Kim, Baek; Stephen, Sam L.; Hanby, Andrew M.; Horgan, Kieran; Perry, Sarah L.; Richardson, Julie; Roundhill, Elizabeth A.; Valleley, Elizabeth M. A.; Verghese, Eldo T.; Williams, Bethany J.; Thorne, James L.; Hughes, Thomas A. // BMC Cancer;9/12/2015, Vol. 15 Issue 1, p1 

    Background: Multi-drug Resistance associated Protein-1 (MRP1) can export chemotherapeutics from cancer cells and is implicated in chemoresistance, particularly as is it known to be up-regulated by chemotherapeutics. Our aims in this study were to determine whether activation of...

  • Drug resistance in chemotherapy for breast cancer. Saeki, Toshiaki; Tsuruo, Takashi; Sato, Wakao; Nishikawsa, Kiyoshiro // Cancer Chemotherapy & Pharmacology;Nov2005, Vol. 56, p84 

    Recent developments with chemotherapy for breast cancer have improved patient survival. However, there continue to be nonresponders to conventional anticancer agents. Multidrug resistance (MDR) is caused by the expression of P-glycoprotein (P-gp) on the cell membrane. The expression of P-gp is...

  • Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma. Susa, Michiro; Iyer, Arun K.; Ryu, Keinosuke; Choy, Edwin; Hornicek, Francis J.; Mankin, Henry; Milane, Lara; Amiji, Mansoor M.; Zhenfeng Duan // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    Background: The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year survival rate from 20% to 70% in the past 30 years. However, for patients who progress after chemotherapy, its effectiveness diminishes due to the emergence of multi-drug resistance...

  • KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma. Li, Qing Kay; Singh, Anju; Biswal, Shyam; Askin, Frederic; Gabrielson, Edward // Journal of Human Genetics;Mar2011, Vol. 56 Issue 3, p230 

    Distinctive histological variants of lung cancer are increasingly recognized to have specific genetic changes that affect tumor biology and response to therapy. In this study, we evaluated true papillary adenocarcinoma of the lung, proposed as a distinct diagnostic category with relatively poor...

  • Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar. Sun, Yue-Li; Chen, Jun-Jiang; Kumar, Priyank; Chen, Kang; Sodani, Kamlesh; Patel, Atish; Chen, Yang-Lu; Chen, Si-Dong; Jiang, Wen-Qi; Chen, Zhe-Sheng // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cassette (ABC) family which are capable of conferring resistance to a variety of anticancer drugs, including taxanes and nucleoside analogs, in vivo. MRP7 is highly expressed in non-small cell lung...

  • The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549). Vilanova-Costa, Cesar; Porto, Hellen; Pereira, Flávia de; Lima, Aliny; Santos, Wagner; Silveira-Lacerda, Elisângela de // BioMetals;Jun2014, Vol. 27 Issue 3, p459 

    Lung cancer is one of the leading causes of death in the world, and non-small cell lung carcinoma accounts for approximately 75-85 % of all lung cancers. In the present work, we studied the antitumor activity of the compound cis-(dichloro)tetramineruthenium(III) chloride { cis-[RuCl(NH)]Cl}...

  • Short Double-Stranded RNA Suppresses Multiple Drug Resistance Gene Expression in Tumor Cells. Logashenko, E. B.; Chernolovskaya, E. L.; Vladimirova, A. V.; Repkova, M. N.; Ven'yaminova, A. G.; Vlasov, V. V. // Doklady Biochemistry & Biophysics;Sep/Oct2002, Vol. 386 Issue 1-6, p296 

    Discusses research on the role of synthetic 21-bp double-stranded oligoribonucleotides in suppressing the expression of the mdr1 gene in KB-8-5 tumor cells. Description of the KB-8-5 cells; Experimental procedure of the study; Explanation on the genetic regulation of tumor cells by the...

  • Effects of Multidrug Resistance Gene Expression in Acute Erythroleukemia. Mazzella, Femina M.; Kowal-Vern, Areta; Shrit, M. Atef; Rector, James T.; Cotelingam, James D.; Schumacher, Harold R. // Modern Pathology;Apr2000, Vol. 13 Issue 4, p407 

    Acute erythroleukemia is a relatively rare disorder of a multilineal nature. Patients with this type of leukemia traditionally have been treated with a standard myeloid protocol, with a wide variation in prognosis between M6a, which has a similar prognosis to acute myelogenous leukemias, and...

  • Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Hu, Yunhui; Cheng, Xin; Li, Shuangjing; Zhou, Yuan; Wang, Jianxiang; Cheng, Tao; Yang, Ming; Xiong, Dongsheng // Cancer Chemotherapy & Pharmacology;Oct2013, Vol. 72 Issue 4, p789 

    Purpose: Sorcin, a 22-kDa calcium-binding protein, renders cancer cells resistant to chemotherapeutic agents, thus playing an important role in multidrug resistance (MDR). But the mechanisms mediated by sorcin still remain quite elusive. This study aim to explore whether sorcin silencing could...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics